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Abstract
In addition to its well-known glycolytic activity, GAPDH 
displays multiple functions, such as nuclear RNA ex-
port, DNA replication and repair, and apoptotic cell 
death. This functional diversity depends on its intra-
cellular localization. In this study, we explored the sig-
nal transduction pathways involved in the nuclear 
translocation of GAPDH using confocal laser scanning 
microscopy of immunostained human diploid fibro-
blasts (HDFs). GAPDH was present mainly in the cyto-
plasm when cultured with 10% FBS. Serum depletion 
by culturing cells in a serum-free medium (SFM) led to 
a gradual accumulation of GAPDH in the nucleus, and 
this nuclear accumulation was reversed by the re-addi-
tion of serum or growth factors, such as PDGF and lyso-
phosphatidic acid. The nuclear export induced by the 
re-addition of serum or growth factors was prevented 
by LY 294002 and SH-5, inhibitors of phosphoinositide 
3-kinase (PI3K) and Akt/protein kinase B, respectively, 
suggesting an involvement of the PI3K signaling path-
way in the nuclear export of GAPDH. In addition, 5-ami-
noimidazole-4-carboxamide-1-β-D-ribofuranoside 
(AICAR), an activator of AMP-activated protein kinase 
(AMPK), stimulated the nuclear translocation of 
GAPDH and prevented serum- and growth factor-in-
duced GAPDH export. AMPK inhibition by compound 
C or AMPK depletion by siRNA treatment partially pre-
vented SFM- and AICAR-induced nuclear trans-
location of GAPDH. Our data suggest that the nuclear 
translocation of GAPDH might be regulated by the PI3K 
signaling pathway acting mainly as a nuclear export 
signal and the AMPK signaling pathway acting as a nu-
clear import signal.
Keywords: AICA ribonucleotide; AMP-actived pro-
tein kinases; fibroblasts; glyceraldehyde-3-phos-
phate dehydrogenase (phosphorylating); 1-phospha-
tidylinositol 3-kinase
Introduction
GAPDH (E.C. 1.2.1.12) functions as a glycolytic 
enzyme working within the cytoplasm. GAPDH 
forms a tetramer to be active and catalyzes the 
oxidative phosphorylation of glyceraldehyde 3-pho-
sphate, producing 1,3-bisphosphoglycerate. Cys-
teine and histidine are located in the active site. 
Besides its role in glycolysis, GAPDH is also 
involved in several biological functions, including 
the organization of the cytoskeleton and regulation 
of endocytosis, binding and transport of tRNA, and 
regulation of translation, transcription, replication, 
DNA repair, cell proliferation, and apoptosis 
(Sirover, 2005; Harada et al., 2007). Its diverse 
activities appear to be regulated according to its 
oligomeric structure and subcellular localization to 
the nucleus and other subcellular organelles such 
as mitochondria and the cytoskeleton (Barbini et 
al., 2007). The nuclear translocation of GAPDH 
upon apoptosis (Sawa et al., 1997; Shashidharan 
et al., 1999; Du et al., 2007), serum deprivation 
(Schmitz, 2001; Schmitz et al., 2003), oxidative 
stresses (Dastoor and Dreyer, 2001), and genotoxic 
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stresses (Brown et al., 2004) has been reported.
    Analysis of the growth factor signaling pathway 
with specific inhibitors has revealed that the 
nuclear export of GAPDH is prevented by LY 
294002, an inhibitor of phosphoinositide 3-kinase 
(PI3K) (Schmitz, 2001). Because PI3K links the 
growth factor signaling pathway with cell death via 
the repression of an apoptotic inducer, they have 
suggested that the nuclear accumulation of 
GAPDH upon growth factor depletion might be 
reversed by PI3K-induced survival signals (Schmitz, 
2001). Activated PI3K produces phosphatidyl in-
ositol 3,4,5-triphosphate (PIP3), which interacts 
with a variety of molecules, such as Akt kinase 
(also called PKB) via pleckstrin homology (PH) 
domains of these downstream targets (Cooray, 
2004). The interaction of PIP3 with Akt allows the 
phosphorylation of Akt by PDK1/2 at two key 
regulatory sites, Thr308 and Ser473 near the 
C-terminus, and the subsequent activation of Akt 
(Rameh and Cantley, 1999). Akt is a serine/threo-
nine kinase that phosphorylates many different 
target proteins including GSK-3β, Bad, caspase-9, 
forkhead transcription factors and NF-kB (Cooray, 
2004).
    AMP-activated protein kinase (AMPK) is a hete-
rotrimeric serine/threonine protein kinase consist-
ing of a catalytic α subunit and regulatory β and γ 
subunit. AMPK activity can be regulated by a low 
energy state (increases in the AMP/ATP ratio), 
phosphorylation of Thr172 and Ser485/491 of the α 
subunit, and stresses such as reactive oxygen 
species (ROS), hypoxia, and genotoxic drugs 
(Stein et al., 2000; Hawley et al., 2003; Hurley et 
al., 2006). AMPK has various cellular functions, 
including the regulation of cellular metabolism, ion 
channels, and gene expression (Hardie, 2004), 
activation of glucose transport during hypoxia and 
ischemia via eNOS phosphorylation (Li et al., 
2004), cell cycle arrest via p53 phosphorylation 
(Jones et al., 2005), differentiation of endothelial 
progenitor cells via eNOS activation (Li et al., 
2008), inhibition of protein synthesis via TSC1/2, 
induction of aortic vasorelaxation in mice (Goirand 
et al., 2007), and regulation of apoptotic cell death 
signals (Cao et al., 2008; Kim et al., 2008; Lee et 
al., 2009).
    Since both PI3K/Akt and AMPK are responsive 
to serum and growth factors, and an AMPK 
activator, 5-aminoimidazole-4-carboxamide-1-β-D- 
ribofuranoside (AICAR), has been shown to inhibit 
the PI3K signaling pathway (Jhun et al., 2004), we 
postulated that the PI3K and AMPK signal trans-
duction pathways might contribute to GAPDH 
translocation. Following serum depletion (by cul-
turing in serum-free medium, SFM) and the 
re-addition of serum (by culturing in FBS), PDGF, 
and lysophosphatidic acid (LPA), we examined the 
intracellular distribution of GAPDH by confocal 
laser scanning microscopy of immunostained 
human diploid fibroblasts (HDFs). The involvement 
of the PI3K signaling pathway was examined using 
inhibitors of PI3K and Akt, LY 294002 and SH-5, 
respectively. The role of AMPK was examined 
using an inhibitor of AMPK (compound C), an 
activator of AMPK (AICAR), and siRNAs of AMPK. 
In addition, we examined the involvement of NOS 
and p53 in GAPDH nuclear localization using NOS 
inhibitors, N-nitro-L-arginine methyl ester (L-NAME) 
and N-monomethyl-L-arginine (L-NMMA), and p53- 
null cells, MEF-p53-/- and HCT116-p53-/-.
Results
Reversible translocation of GAPDH between the 
cytosol and nucleus by the availability of serum and 
growth factors
Because serum depletion had no influence on the 
total GAPDH expression level, we investigated the 
intracellular distribution of GAPDH by confocal 
laser scanning microscopy of immunostained 
HDFs (Figures 1A and 1B). Cells in which green 
FITC fluorescence was present in the cytosol, but 
absent or weak in the nuclear fraction, were 
counted as cells with cytosolic GAPDH. Cells with 
dense bright green fluorescence only in the 
nucleus were counted as cells with nuclear 
GAPDH. Cells containing green fluorescence 
evenly in both the nuclear and cytosolic fractions 
were counted as cells with cytosolic and nuclear 
GAPDH (Figure 1B). To compare the distribution of 
GAPDH between the cytosol and nucleus, the 
percent distributions of cells with cytosolic GAPDH 
(cytosol: black bar) or nuclear GAPDH alone 
(nuclear: white bar), and cells with both cytosolic 
and nuclear GAPDH (cytosol + nuclear: gray bar) 
were plotted in Figure 1C.
    Almost all GAPDH was present in the cytosol of 
HDFs with a population doubling of less than 25 
(designated as young HDFs in other reports) when 
they were cultured in DMEM containing 10% FBS 
for 2 days (Figure 1A, 10% FBS and Figure 1C, 
FBS). Serum withdrawal from young HDFs for 1 
day initiated an accumulation of GAPDH in the 
nucleus, and its nuclear accumulation increased 
gradually until 5 days (Figure 1A, 10% 
FBS/SFM-5d). The number of cells with cytosolic 
GAPDH alone decreased such that the number of 
cells with nuclear GAPDH increased gradually to 
over 90% in young cells with serum depletion for 
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Figure 1. Effect of serum depletion on the intracellular distribution of 
GAPDH. HDFs were maintained in culture medium containing 10% FBS 
for 2 days and then serum-depleted by incubation with SFM for the times 
indicated (1-5 days). Cells were immunostained with monoclonal an-
ti-GAPDH antibody (1:1,000) and FITC-conjugated anti-mouse secon-
dary antibodies, and analyzed by confocal laser scanning microscopy. 
Immunostained cells without (10% FBS) and with serum depletion for 3 
days (SFM-3d) or 5 days (SFM-5d) are shown in (A). Representative cell 
with green FITC fluorescence present in the cytosol, but absent or weak 
in the nuclear fraction (cytosolic GAPDH), cell with dense, bright green 
fluorescence only in the nucleus (nuclear GAPDH, cell with green fluo-
rescence equally distributed in both the nuclear and cytosolic fractions 
(cytosol + nuclear GAPDH) are shown in (B). The number of cells with 
cytosolic GAPDH alone (cytosol: black bar), nuclear and cytosolic 
GAPDH (cytosol + nuclear: gray bar) or nuclear GAPDH alone (nuclear: 
white bar) was counted and the percentage distributions are plotted as 
means ± standard deviations in (C). The results shown are representa-
tive of three independent experiments.
4-5 days (Figure 1C, SFM).
    Nuclear export of GAPDH to the cytosol was 
observed upon the addition of serum to HDFs that 
had been serum-deprived for 5 days (Figure 2A, 
SFM-5d/10% FBS). After 2 days of incubation with 
10% FBS, over 90% of the GAPDH had been 
released back to the cytosol (Figures 2A and 2B). 
Our data suggest that GAPDH nuclear translo-
cation is a reversible process in HDFs. A portion 
(∼60%) of the nuclear GAPDH in serum-deprived 
cells was also exported by treatment with 100 
ng/ml PDGF for 24-48 h (Figure 2C) or 30 μM LPA 
for 48 h (Figure 2D).
PI3K-dependent export of nuclear GAPDH to the 
cytoplasm
The cell number with nuclear GAPDH alone was 
combined with that including both nuclear and 
cytosolic GAPDH to illustrate the effects of inhi-
bitors and activators (nuclear +/- cytosol in Figures 
3-5 and 7-9). An inhibitor of PI3K, LY 294002, 
induced the nuclear accumulation of GAPDH 
significantly (P ＜ 0.001) at concentrations of 10-50 
μM, even when cultured in 10% FBS for 2 days 
(Figure 3A). After serum depletion for 5 days, the 
medium was replaced with 10% FBS, 100 ng/ml 
PDGF, or 30 μM LPA in the presence and absence 
of 50 μM LY 294002. As shown in Figure 3B, the 
nuclear export induced by the re-addition of 10% 
FBS, PDGF, or LPA was (P ＜ 0.001) prevented 
completely by the PI3K inhibitor, LY 294002.
    SH-5, an inhibitor of PI3K-downstream kinase 
Akt, also induced the nuclear translocation of 
GAPDH significantly (P ＜ 0.01) at a concentration 
of 20 μM when cultured in 10% FBS (Figure 3C). 
This concentration of SH-5 reduced partially but 
significantly (P ＜ 0.001) the serum-induced GAPDH 
export (Figure 3D). Because the effect of SH-5 was 
less than that of LY 294002, we used Western blot 
analysis to compare the efficacy of LY 294002 and 
SH-5 on the phosphorylation of downstream sub-
strates such as Akt, GSK3β, and Bad. As shown in 
Figure 3E, Ly 294002 completely inhibited Akt 
phosphorylation but only partially inhibited GSK3β 
phosphorylation. Similarly, SH-5 only partially inhi-
bited the phosphorylation of GSK3β and Bad, two 
downstream signaling proteins of Akt. Although the 
reason why the Akt inhibitor is less effective re-
mains elusive, our data suggest that the PI3K/Akt 
signaling pathway is involved in the nuclear export 
of GAPDH in HDFs.
AICAR affects nuclear localization of GAPDH
To examine the involvement of AMPK in GAPDH 
translocation, we first examined the effect of 
AICAR, a specific AMPK activator, on GAPDH 
nuclear localization. HDFs were grown in culture 
medium containing 10% FBS for 2 days and then 
grown further in fresh culture medium with 0.5-2 
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Figure 2. Effect of serum and growth factor re-addition on the nuclear GAPDH export after serum depletion. HDFs grown on 10% FBS culture medium 
were serum-depleted by incubation in SFM for 5 days. Next, 10% FBS was re-added to the serum-depleted cells for the times indicated (1-3 days). Cells 
were immunostained against GAPDH and analyzed by confocal laser scanning microscopy, as described in Figure 1. Immunostained cells with serum de-
pletion for 5 days (SFM-5d) and re-addition of 10% FBS for 1-3 days (SFM-5d/10% FBS-1d to -3d) are shown in (A). The number of cells with cytosolic 
GAPDH alone, nuclear and cytosolic GAPDH, or nuclear GAPDH alone was counted and the percentage distributions are plotted in (B), as described in 
Figure 1B. Instead of FBS, 100 ng/ml PDGF (C) or 30 μM LPA (D) was re-added to the serum-depleted cells for the times indicated (1-48 h).
mM AICAR for 1-4 days. AICAR by itself stimulated 
the nuclear translocation of GAPDH in a dose- and 
time-dependent manner (Figures 4A and 4B, re-
spectively). About 60% of the cytosolic GAPDH 
was translocated to the nucleus after 4 days of 
treatment with 0.5 mM AICAR (P ＜ 0.001) and its 
translocation increased to over 90% by 2 mM 
AICAR treatment for 4 days (Figures 4A and 4B). 
After GAPDH had localized to the nucleus by 
serum depletion for 4 days, the effect of AICAR on 
the nuclear export of GAPDH by FBS was also 
examined. In the presence of 0.5-2 mM AICAR, 
nuclear GAPDH was not exported to the cytosol 
upon serum re-addition (Figure 4C).
    To work as a specific activator of AMPK, AICAR 
should be internalized and become phosphorylated 
by adenosine kinase to form AICAR-monophos-
phate (AICA ribotide, ZMP) (Vincent et al., 1996). 
ZMP mimics the effects of AMP on AMPK (Corton 
et al., 1995). Therefore, we first examined whether 
the AICAR-induced nuclear accumulation of 
GAPDH depends on AICAR uptake and sub-
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Figure 3. Effect of inhibitors of PI3K and Akt on the intracellular distribution of GAPDH. (A) HDFs were incubated in culture medium containing 10% FBS 
and treated with vehicle (DMSO) or various concentrations of the PI3K inhibitor LY 294002 (10-50 μM) for 2 days. Cells were immunostained against 
GAPDH and analyzed by confocal laser scanning microscopy, as described in Figure 1. The number of cells with cytosolic GAPDH alone (cytosol: black 
bar) and cells having nuclear GAPDH with or without cytosolic GAPDH (nuclear +/- cytosol: red bar) was counted and the percent distributions are plotted 
as means ± standard deviations. ***P ＜ 0.001, comparison between the FBS control and FBS + LY 294002 (μM). (B) HDFs were serum-depleted by 
incubating in SFM for 4 days, and then either 10% FBS, 100 ng/ml PDGF, or 30 μM LPA was re-added to serum-depleted cells in the absence (-) or pres-
ence (+) of 50 μM LY 294002 for 2 days. **P ＜ 0.01 and ***P ＜ 0.001, comparison between the absence (-) and presence (+) of LY 294002. (C) HDFs 
were incubated in medium containing 10% FBS and treated with vehicle (DMSO) or various concentrations of the Akt inhibitor SH-5 (5-20 μM) for 2 days. 
**P ＜ 0.01, comparison between the FBS control and FBS + SH-5 (μM). (D) HDFs were serum-depleted by incubating in SFM for 4 days, and then ei-
ther 10% FBS, 100 ng/ml PDGF, or 30 μM LPA was re-added to serum-depleted cells in the absence (-) or presence (+) of 20 μM SH-5 for 2 days. **P ＜
0.01 and ***P ＜ 0.001, comparison between the absence (-) and presence (+) of SH-5. The results shown are representative of more than three in-
dependent experiments. Serum-starved HDF cells were pre-incubated with vehicle (-), 50 μM LY 294002 (E, +), or 20 μM SH-5 (F, +). Cells were treated 
with 10% FBS/DMEM for 30 min and then lysed. Total cell extract (30 μg per lane) was resolved by 10% PAGE and analyzed by Western blot analysis, 
using specific antibodies against phospho (Ser473)-Akt, total Akt, phospho (Ser8)-GSK-3β, total GSK-3β, phospho-Bad, total Bad, and β-actin as a control 
(1:1,000 dilutions).
sequent phosphorylation to ZMP using an ade-
nosine kinase inhibitor, 5'-iodotubercidin (5'-ITC). 
Within the concentration range of 0.1-1 μM, 5'-ITC 
increased a low but significant (P ＜ 0.001) nuclear 
export of GAPDH in a dose-dependent manner, 
while at higher concentrations, such as 2 μM, it 
enhanced the level of nuclear GAPDH slightly 
(Figure 5A). After serum depletion for 4 days, 
FBS-induced GAPDH export was also examined in 
the presence of 5'-ITC. The lower concentrations 
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Figure 4. Effect of AICAR on GAPDH distribution. (A) HDFs were incubated in medium containing 10% FBS and treated with vehicle (PBS) or various 
concentrations of AICAR (0.5-2 mM) for 4 days. Cells were immunostained and analyzed by confocal laser scanning microscopy, as described in Figure 1. 
The number of cells with cytosolic GAPDH alone (cytosol) and cells having nuclear GAPDH with or without cytosolic GAPDH (nuclear +/- cytosol) was 
counted and the percent distributions are plotted as means ± standard deviations. ***P ＜ 0.001, comparison between the FBS control and FBS +
AICAR (mM). (B) HDFs were incubated in medium containing 10% FBS and treated with vehicle (PBS) or 2 mM AICAR for the times indicated (1-4 days). 
***P ＜ 0.001, comparison between the FBS control and FBS + 2 mM AICAR. (C) HDFs were serum-depleted by incubating in SFM for 4 days (SFM-4d), 
and then 10% FBS was re-added to serum-depleted cells and treated with vehicle (0) or various concentrations of AICAR (0.5-2 mM) for 2 days. ***P ＜
0.001, comparison between the FBS control (0) and FBS + AICAR (mM) after SFM-4d. (D) HDFs were serum-depleted by incubating in SFM for 4 days, 
and then either 10% FBS, 100 ng/ml PDGF, or 30 μM LPA was re-added to serum-depleted cells in the absence (-) or presence (+) of 1 mM AICAR for 2 
days. **P ＜ 0.01 and ***P ＜ 0.001, comparison between the absence (-) and presence (+) of 1 mM AICAR. The results shown are representative of 
more than three independent experiments.
of 5'-ITC did not affect FBS-induced GAPDH 
export, but 5'-ITC concentrations as high as 2 μM 
resulted in about 70% nuclear GAPDH (Figure 5B). 
The AICAR-induced nuclear accumulation was 
partially but significantly (P ＜ 0.001) reduced in 
the presence of various doses of 5'-ITC, compared 
to the level observed in the presence of 2 mM 
AICAR only (Figure 5C). Over 90% of the cytosolic 
GAPDH was translocated to the nucleus after 4 
days of treatment with SFM, and then most 
GAPDH was released by the addition of 10% FBS. 
We also observed that 2 mM AICAR blocked 
FBS-induced release, and this AICAR effect was 
reduced significantly (P ＜ 0.001) in the presence 
of lower concentrations (0.1-0.5 μM) of 5'-ITC 
(Figure 5D). Our data indicate that the AMPK 
activation via ZMP production from AICAR may 
contribute to the AICAR-induced nuclear GAPDH 
accumulation. Because the nuclear GAPDH in-
creased at the higher concentrations (1-2 μM) of 
5'-ITC under most conditions, these 5'-ITC 
concentrations may exert a cellular toxic effect, 
resulting in nuclear GAPDH accumulation.
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Figure 5. Effect of the adenosine kinase inhibitor 5'-ITC on the GAPDH distribution. (A) HDFs were incubated in medium containing 10% FBS and treated 
with vehicle (DMSO) or various concentrations (0.1-2 μM) of the adenosine kinase inhibitor 5'-ITC for 2 days. Cells were immunostained and analyzed by 
confocal laser scanning microscopy, as described in Figure 1. The number of cells with cytosolic GAPDH alone (cytosol) and cells having nuclear GAPDH 
with or without cytosolic GAPDH (nuclear +/- cytosol) was counted, and the percent distributions are plotted as means ± standard deviations. ***P ＜
0.001, comparison between the FBS control and FBS + 5'-ITC (μM). (B) HDFs were serum-depleted by incubating in SFM for 4 days (SFM-4d) and then 
10% FBS was re-added to serum-depleted cells and treated with vehicle (0) or various concentrations of 5'-ITC (0.1-2 μM) for 2 days. ***P ＜ 0.001, 
comparison between the FBS control (0) and FBS + 5'-ITC (μM) after SFM-4d. (C) HDFs were incubated in a culture medium containing 10% FBS for 2 
days and then treated with 2 mM AICAR in the absence (0) or presence of various concentrations of 5'-ITC (0.1-2 μM) for 2 days. ***P ＜ 0.001, compar-
ison between 2 mM AICAR only without compound C (0) and 2 mM AICAR + 5'-ITC (μM). (D) HDFs were serum-depleted by incubating in SFM for 4 days 
(SFM-4d), and then 10% FBS was re-added to serum-depleted cells with 2 mM AICAR in the absence (0) or presence of various concentrations of 5'-ITC 
(0.1-2 μM) for 2 days. ***P ＜ 0.001, comparison between the AICAR/10%FBS control (0) and AICAR/10%FBS + 5'-ITC (μM) after SFM-4d.
AMPK is involved in SFM- and AICAR-dependent 
nuclear translocation of GAPDH
To confirm that SFM- and AICAR-induced GAPDH 
nuclear translocation was mediated through AMPK 
activation, we examined the effect of an AMPK 
inhibitor, compound C, on the GAPDH distribution. 
Compound C in the culture medium with 10% FBS 
induced GAPDH translocation to the nucleus 
significantly (P ＜ 0.001) in a dose- and time- 
dependent manner (Figures 6A and 6B, respec-
tively). Moreover, compound C prevented SFM- 
and AICAR-induced GAPDH translocation (Figures 
6C and 6D, respectively).
    Because the inhibition of SFM- and AICAR- 
induced GAPDH translocation by 10 μM compound 
C was significant (P ＜ 0.001) but only partial 
(about 60%), we examined the effect of compound 
C on SFM- and AICAR-induced AMPK activation 
by measuring the phosphorylation status of AMPK 
and its target substrate (acetyl-CoA carboxylase: 
ACC) through Western blot analysis. A partial 
inhibitory effect of 10 μM compound C on SFM- 
induced phosphorylation of AMPK and ACC was 
observed (Figure 7A). In addition, the same 
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Figure 6. Effect of the AMPK inhibitor compound C on the GAPDH distribution. (A) HDFs were incubated in medium containing 10% FBS and treated with 
vehicle (DMSO) or various concentrations of the AMPK inhibitor compound C (1-10 μM) for 2 days. Cells were immunostained and analyzed by confocal 
laser scanning microscopy, as described in Figure 1. The number of cells with cytosolic GAPDH alone (cytosol) and cells having nuclear GAPDH with or 
without cytosolic GAPDH (nuclear +/- cytosol) was counted and the percent distributions are plotted as means ± standard deviations. ***P ＜ 0.001, 
comparison between the FBS control and FBS + compound C (μM). (B) HDFs were incubated in medium containing 10% FBS and treated with vehicle 
(DMSO) or 10 μM of compound C for the times indicated (1-4 days). **P ＜ 0.01 and ***P ＜ 0.001, comparison between the FBS control and FBS + 10 
μM compound C. (C) HDFs grown in 10% FBS culture medium were serum-depleted by incubating in SFM for 4 days (SFM-4d) without (0) or with various 
concentrations of compound C (1-10 μM). ***P ＜ 0.001, comparison between SFM-4d without compound C (0) and SFM-4d + compound C (μM). (D) 
HDFs were incubated in medium containing 10% FBS for 2 days and then treated with vehicle (PBS) or 2 mM AICAR in the absence (0) or presence of 
various concentrations of compound C (1-10 μM) for 2 days. ***P ＜ 0.001, comparsion between 2 mM AICAR only without compound C (0) and 2 mM 
AICAR + compound C (μM). The results shown are representative of more than three independent experiments.
amount of compound C partially prevented the 
AICAR-induced phosphorylation of AMPK and 
ACC during a short-term (0.5-2 h), as well as a 
long-term incubation period (2 days) (Figures 7B 
and 7C, respectively). These findings indicate that 
the partial inhibitory effect of compound C might be 
due to a partial inhibition of AMPK activity.
    We also applied an siRNA approach, specific for 
AMPK, to abolish the expression of AMPK 
proteins. AMPKα1 and AMPKα2 are the major 
isoforms of the AMPKα catalytic subunit in HDFs. 
Therefore, we utilized a mixture of siRNAs to block 
the expressions of both AMPKα1 and AMPKα2. As 
depicted in Figure 8A, treatment with AMPKα1/α2 
siRNAs for 2 days reduced the total AMPK protein 
expression and AMPK phosphorylation induced by 
SFM and AICAR. AMPK depletion by siRNA 
treatment significantly (P ＜ 0.001) prevented SFM- 
and AICAR-induced nuclear translocation of 
GAPDH compared to the mock control group 
(Figures 8B and 8C, respectively). Our data 
indicate that AMPK is involved in SFM- and 
AICAR-induced GAPDH translocation in HDFs.
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NOS- and p53-independent nuclear localization of 
GAPDH
Previous studies have suggested that S-nitrosylat-
ion of GAPDH is required for its nuclear trans-
location in apoptotic cancer cells (Hara et al., 2005; 
Hara and Snyder, 2006; Du et al., 2007). However, 
whether S-nitrosylation is necessary for GAPDH 
nuclear translocation in all cell types with various 
stimuli is not known. Therefore, the involvement of 
S-nitrosylation in SFM- and AICAR-induced 
GAPDH nuclear localization in HDF cells was 
examined using the NOS inhibitors L-NMMA and 
L-NAME. We found that GAPDH translocation by 
SFM and AICAR in cells treated with NOS 
inhibitors was similar to that observed in the 
untreated control cells (Figures 9A and 9B, re-
spectively), indicating that NOS activation is not 
necessary for SFM- and AICAR-induced GAPDH 
translocation.
    p53 has been demonstrated to be phosphory-
lated and activated by AMPK (Jones et al., 2005). 
The treatment of cells with AICAR caused cell 
cycle arrest in S-phase accompanied with increa-
sed expression of p21, p27, and p53 proteins 
(Rattan et al., 2005). In addition, p53 could be 
activated by GAPDH nuclear translocation via the 
formation of a GAPDH-Siah1 complex and sub-
sequent activation of p300/CBP in the presence of 
apoptotic stimuli (Sen et al., 2008). To determine 
whether p53 might contribute to GAPDH localiza-
tion, we performed experiments using p53-null 
(p53-/-) MEF and HCT116 cancer cells. SFM and 
AICAR could induce GAPDH nuclear accumulation 
in both normal and p53-null MEF cells (Figures 
10A and 10B, respectively). The effects of SFM 
and AICAR on GAPDH nuclear accumulation were 
significantly (P ＜ 0.001) higher in p53-null MEF 
cells than in normal MEF cells. However, p53-null 
HCT116 cells exhibited little reduction (P ＜ 0.05 at 
day 2, P ＜ 0.001 at day 4) in SFM-induced 
GAPDH nuclear localization compared to normal 
HCT116 cells (Figure 10C). We observed no 
changes in AICAR-induced GAPDH nuclear lo-
calization between normal and p53-null HCT116 
cells (Figure 10D). Our data suggest that p53 
activation may not be necessary for SFM- and 
AICAR-induced GAPDH translocation in both MEF 
cells and HCT116 cancer cells. The activation of 
p53 might play an inhibitory role in GAPDH nuclear 
localization at least in the MEF cell system.
Leptomycin B stimulates nuclear accumulation of 
GAPDH by inhibiting GAPDH export
Recently, the CRM1(chromosome region main-
tenance 1, also called exportin1/Xpo1)-dependent 
nuclear export system has been demonstrated to 
operate in determining GAPDH localization (Brown 
et al., 2004). Because the CRM1-dependent 
nuclear export can be inhibited by leptomycin B 
Figure 7. Detection of phosphorylated AMPK and its substrate ACC by Western blot analysis. 
(A) HDF cells were serum-starved by incubation with SFM for the times indicated (1-4 days) 
in the absence (-) or presence (+) of 10 μM of the AMPK inhibitor compound C. Cells were 
lysed and total cell extract (30 μg per lane) was resolved by 10% PAGE and blotted onto 
Immobilon PVDF membranes for Western blot analysis, as described in the Methods. 
Monoclonal anti-phospho (Thr172)-AMPK and anti-phospho (Ser79) ACC antibodies were used 
at 1:1,000 dilution and polyclonal anti-pan-AMPK and anti-pan-ACC antibodies were used at 
1:500 dilution. (B) HDF cells were treated with vehicle (-) or AICAR (+) in medium containing 
10% FBS for short-term periods (0.5-2 h) in the absence (-) or presence (+) of 10 μM com-
pound C. Primary and secondary antibodies were the same as those used in (A). (C) HDF 
cells were treated with vehicle (-) or AICAR (+) in medium containing 10% FBS for a 
long-term period (2 days) in the absence (-) or presence (+) of 10 μM compound C. Primary 
and secondary antibodies were the same as those used in (A).
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Figure 8. SFM- and AICAR-induced GAPDH translocation in AMPK siRNA-transfected HDFs. HDFs were grown in 10% FBS medium for 1 day and 
transfected with siRNAs of AMPKα1/α2 and a siCONTROL complete kit as a negative mock control for 2 days. Cells were then serum-depleted by in-
cubation with SFM or treated with 2 mM AICAR for 2 days. During the serum depletion or AICAR treatment period, either the mock control siRNAs or 
AMPKα1/α2 siRNAs were included. (A) Cells were harvested 4 days after transfection, and lysates containing the same amount of protein (45 μg) were 
analyzed by Western blot using monoclonal anti-phospho-Thr172-AMPK antibody and polyclonal anti-AMPKα1/2 and anti-β-actin antibodies. (B) HDF cells 
were transfected with siRNAs and treated with SFM (SFM-2d), as described in (A). Cells were immunostained against GAPDH and analyzed by confocal 
laser scanning microscopy, as described in Figure 1. The number of cells with cytosolic GAPDH alone (cytosol) and cells having nuclear GAPDH with or 
without cytosolic GAPDH (nuclear +/- cytosol) was counted, and the percent distributions are plotted as means ± standard deviations. ***P ＜ 0.001, 
comparison between the mock control and AMPK-siRNA. (C) HDF cells were transfected with siRNAs and treated with 2 mM AICAR, as described in (A). 
Cells were immunostained against GAPDH and analyzed by confocal laser scanning microscopy. ***P ＜ 0.001, comparison between the mock control 
and AMPK-siRNA.
(LMB), we examined the effect of different LMB 
concentrations (1-20 ng/ml) in the culture medium 
with 10% FBS for 2 days (Figure 11A) as well as 
the effect of 10 ng/ml LMB treatment for 1-4 days 
(Figure 11B). LMB induced the nuclear accumula-
tion of GAPDH at a dose as low as 1 ng/ml within 1 
day. The nuclear fraction increased to about 50% 
after 2 days of treatment with 10 ng/ml LMB. The 
LMB-induced nuclear accumulation of GAPDH 
reached a plateau at 50%, even after longer 
treatment periods or in the presence of higher 
concentrations of LMB. We also tested the effect of 
LMB on GAPDH export by the re-addition of 10% 
FBS for 2 days following complete serum depletion 
for 4 days. LMB completely prevented FBS-in-
duced GAPDH export at a dose as low as 1 ng/ml 
(Figure 11C). These data suggest that GAPDH 
translocation by serum and growth factors can be 
regulated via the CRM1-dependent nuclear export 
system.
Discussion
GAPDH contains a novel CRM1-dependent nu-
clear export signal (NES) comprising 13 amino 
acids (KKVVKQASEGPLK) in the C-terminal 
domain, and truncation or mutation of this NES 
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Figure 9. Effect of NOS inhibitors on SFM- and AICAR-induced GAPDH translocation. HDFs were cultured in 10% FBS medium, and then treated with 
SFM for 4 days or 2 mM AICAR in 10% FBS in the absence (-) or presence (+) of 100 μM of L-NMMA (A) or 0.5 mg/ml L-NAME (B) for 2 days. Cells were 
immunostained against GAPDH and analyzed by confocal laser scanning microscopy as described in Figure 1. The number of cells with cytosolic GAPDH 
alone (cytosol) and cells having nuclear GAPDH with or without cytosolic GAPDH (nuclear +/- cytosol) was counted, and the percent distributions are plot-
ted as means ± standard deviations. *P ＜ 0.05, comparison between the absence (-) and presence (+) of NOS inhibitors.
abrogated the binding of CRM1 and caused the 
nuclear accumulation of GAPDH (Brown et al., 
2004). Because treatment of cells with the inhibitor 
LMB did not influence the cytoplasmic localization 
of GFP-GAPDH in NIH3T3 fibroblasts (Schmitz et 
al., 2003), the involvement of CRM1 in GAPDH 
export remains controversial. In our experiment, 
we found that LMB completely prevented 
FBS-induced GAPDH export after serum depletion 
for 4 days. This finding supports a positive role of 
CRM1 in serum- and growth factor-induced 
GAPDH nuclear export in HDF cells.
    It has been suggested that the nuclear export of 
estradiol receptor alpha (ERα) depends on CRM1 
as well as PI3K/Akt activation (Lombardi et al., 
2008). Akt-dependent phosphorylation of a fork-
head protein Foxo1 (FKHR) drives its association 
with ERα, thereby triggering the complex export 
from the nucleus. In this study, we found that a 
PI3K inhibitor, LY 29004, inhibited serum- or 
growth factor-induced GAPDH nuclear export in 
HDF cells, which is in agreement with previous 
findings (Schmitz, 2001). Therefore, we suggested 
PI3K as a candidate that regulates GAPDH nuclear 
export in HDF cells but its regulation mechanism is 
not yet clear. A similar forkhead family protein 
might also be associated with GAPDH, and 
perhaps Akt-dependent phosphorylation of these 
forkhead proteins could play a role in GAPDH 
export. This should be verified further.
    GAPDH has been reported to undergo auto-
phosphorylation (Kawamoto and Caswell, 1986) as 
well as phosphorylation via phosphatidylserine-de-
pendent PKCs (Reiss et al., 1996). Although 
GAPDH export was not altered upon inhibition of 
PKC by a general PKC inhibitor bisindolylmale-
imide II in NIH3T3 cells (Schmitz, 2001), we could 
not exclude the possibility that the atypical PKC 
family PKCι/λ could be involved in GAPDH nuclear 
translocation. The atypical PKCs are activated by 
the lipid second messenger PIP3 produced by 
PI3K. PI3K could be activated by EGF- or PDGF- 
receptor tyrosine kinases. In our study, we ob-
served that a PI3K inhibitor, LY 294002, provided a 
dramatic inhibition of GAPDH nuclear export. 
Moreover, GAPDH has been shown to be phos-
phorylated by PKCι/λ and influence microtubule 
dynamics in the early secretory pathway (Tisdale, 
2002, 2003; Tisdale et al., 2004). Src-dependent 
PKCι/λ tyrosine phosphorylation is required for 
PKCι/λ association with Rab2 and GAPDH on 
pre-Golgi intermediates (Tisdale and Artalejo, 
2006). Therefore, it is possible that PIP3-induced 
atypical PKCι/λ might be involved in GAPDH 
nuclear translocation.
    Because GAPDH also possesses a region 
homologous to a nuclear localization sequence 
motif (NLS) between amino acids 259 and 263 
(KKVVK), its nuclear transport could occur via this 
NLS (Sirover, 1999). However, possible regulatory 
proteins and signaling pathways have not been 
elucidated. In the current study, we found that a 
well-known AMPK activator AICAR induced 
GAPDH nuclear translocation and an adenosine 
kinase inhibitor 5'-ITC abrogated this change. In 
the presence of AMPK inhibitors and siRNAs for 
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Figure 10. SFM- and AICAR-induced GAPDH translocation in p53-null cells. Normal and p53-null MEF cells (A and B) and HCT116 cells (C and D) were 
cultured in 10% FBS medium and then treated with SFM for the times indicated (A and C) or with various concentrations of AICAR in 10% FBS for 2 days 
(B and D). Cells were immunostained against GAPDH and analyzed by confocal laser scanning microscopy, as described in Figure 1. The number of cells 
with cytosolic GAPDH alone (cytosol) and cells having nuclear GAPDH with or without cytosolic GAPDH (nuclear +/- cytosol) was counted, and the per-
cent distributions are plotted as means ± standard deviations. *P ＜ 0.05 and ***P ＜ 0.001, comparison between normal cells and p53-null cells.
the inhibition of AMPK activity and blockage of 
AMPK expression, respectively, we also observed 
an inhibition of GAPDH translocation. These data 
suggest that AMPK activation via ZMP production 
from AICAR may play a role in the nuclear 
accumulation of GAPDH. Because AICAR inhibits 
the PI3K/Akt signaling pathway in an AMPK- 
dependent (Peairs et al., 2009) or AMPK-indepen-
dent manner (Jhun et al., 2004), a part of AICAR 
effect on GAPDH nuclear accumulation might be 
explained by the negative effect on the PI3K/Akt 
signaling pathway.
    AMPK directly phosphorylates and activates p53 
(Jones et al., 2005) and AICAR increases p53 
expression (Rattan et al., 2005). In addition, p53 
could be activated by GAPDH nuclear translo-
cation via the formation of GAPDH-Siah1 com-
plexes (Sen et al., 2008). In our experiments, SFM 
and AICAR induced GAPDH nuclear accumulation 
in both normal (p53+/+) and p53-null (p53-/-) MEF 
and HCT116 cells. Therefore, we suggest that p53 
activation may not be necessary for SFM- and 
AICAR-induced GAPDH translocation in MEF and 
HCT116 cells.
    Because AMPK phosphorylates endothelial 
NOS on Ser633 and control NO bioavailability in 
vascular endothelial cells (ECs) (Chen et al., 
2009), and S-nitrosylated GAPDH can be translo-
cated to the nucleus under diverse apoptotic 
stimuli (Hara et al., 2005; Hara and Snyder, 2006; 
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Figure 11. Effect of the CRM1 inhibitor LMB on the GAPDH distribution. 
HDFs were cultured in 10% FBS medium for 2 days and treated with ve-
hicle (methanol) or various concentrations of LMB (1-20 ng/ml) for 2 days 
(A) or with 10 ng/ml LMB for the times indicated (B). In another experi-
ment (C), HDFs were cultured in 10% FBS medium and serum-depleted 
by incubation with SFM for 4 days (SFM-4d). FBS was added to se-
rum-depleted cells in the absence (0) or presence of various concen-
trations of LMB for 2 days. Cells were immunostained against GAPDH 
and analyzed by confocal laser scanning microscopy, as described in 
Figure 1. The number of cells with cytosolic GAPDH alone (cytosol) and 
cells having nuclear GAPDH with or without cytosolic GAPDH (nuclear 
+/- cytosol) was counted, and the percent distributions are plotted as 
means ± standard deviations. ***P ＜ 0.001, comparison between the 
FBS control (0) and FBS + LMB (ng/ml).
Du et al., 2007), we investigated the involvement of 
NOS in SFM- and AICAR-induced GAPDH nuclear 
localization using NOS inhibitors. We observed no 
effects of NOS inhibitors, such as L-NMMA and 
L-NAME, on the nuclear translocation of GAPDH, 
suggesting that S-nitrosylation of GAPDH may not 
be necessary for SFM- and AICAR-induced 
nuclear translocation in this cell system.
    Based on the current findings, we propose sig-
nal transduction pathways involved in the nuclear 
translocation of GAPDH (Figure 12). GAPDH 
exists mainly in the cytoplasm in the presence of 
serum and growth factors. When cells are 
serum-depleted by SFM or treated with AICAR, 
GAPDH moves to the nucleus. The re-addition of 
serum or growth factors to serum-depleted cells 
causes an export of nuclear GAPDH, which 
requires the PI3K/Akt signal transduction pathway. 
The inhibition of PI3K and Akt by LY 294002 and 
SH-5, respectively, prevents GAPDH export and 
causes GAPDH accumulation in the nucleus. In 
contrast, the depletion of serum or growth factors, 
or treatment with AICAR results in AMPK acti-
vation, which may play a role in the nuclear 
translocation of GAPDH.
    Taken together, we conclude that serum-depen-
dent signaling pathways may regulate any import 
or export processes of GAPDH. The PI3K/Akt 
signaling pathway regulates the GAPDH nuclear 
export signal positively or the nuclear import signal 
negatively. The AMPK signaling pathway, however, 
works in the opposite way, regulating the GAPDH 
nuclear import signal positively and its export 
signal negatively. The involvement of other signal-
ing pathways should be investigated further to 




The followings are the reagents used in this study and their 
sources: PDGF-BB, LPA, LMB, FITC-conjugated goat anti- 
mouse secondary antibody, and mouse anti-β-actin mono-
clonal antibody from Sigma-Aldrich (St. Louis, MO); 
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Figure 12. Proposed signal transduction pathways involved in the nu-
clear translocation of GAPDH. GAPDH (G in the figure) is present mainly 
in the cytoplasm in the presence of serum and growth factors. When 
cells are serum-depleted by incubation with SFM or treated with the 
AMPK activator AICAR, GAPDH moves to the nucleus. The re-addition 
of serum or growth factors to serum-depleted cells causes an export of 
nuclear GAPDH. An export of nuclear GAPDH requires the PI3K/Akt sig-
nal transduction pathway. Inhibition of PI3K and Akt by LY 294002 and 
SH-5, respectively, prevents GAPDH export and causes GAPDH accu-
mulation in the nucleus. GAPDH translocation by serum and growth fac-
tors may be regulated via the CRM1-dependent nuclear export system, 
as judged by the inhibitory effect of LMB on GAPDH export. In contrast, 
the depletion of serum or growth factors (SFM) results in AMPK activa-
tion, which may play a role in the nuclear translocation of GAPDH. AMPK 
activation by AICAR via ZMP production also causes GAPDH trans-
location to the nucleus. AMPK inhibition by compound C or AMPK deple-
tion by siRNA treatment prevents SFM- and AICAR-induced nuclear 
translocation of GAPDH. The inhibition of ZMP production from AICAR 
by the adenosine kinase inhibitor 5'-ITC reduces the AICAR-induced nu-
clear accumulation of GAPDH.
DMEM, FBS, penicillin, and streptomycin from Gibco/BRL 
Life Technologies, Inc (Carlsbad, CA); PI3K inhibitor LY 
294002, anti-rabbit monoclonal antibodies against 
phospho-AMPKα (Thr172) and GSK-3β (Ser9), anti-mouse 
monoclonal antibodies against phospho-Bad (Ser136) and 
phospho-Akt (Ser473), and anti-rabbit polyclonal antibodies 
against AMPK-α, Akt, and GSK-3β from Cell Signaling 
Technology (Denver, MA); compound C, AICAR, SH-5, 
L-NAME, and L-NMMA from Calbiochem (San Diego, CA); 
mouse anti-GAPDH monoclonal antibody from Chemicon 
(Bedford, MA); anti-rabbit monoclonal antibodies against 
ACC1 and phospho-ACC1 (Ser79) from Upstate (Waltham, 
MA); horseradish peroxidase (HRP)-conjugated anti-rabbit 
and anti-mouse secondary antibodies from Vector 
Laboratories (Burlingame, CA); LipofectamineTM RNAiMAX 
and mounting solution including DAPI from Invitrogen Life 
Technologies (Carlsbad, CA); protein assay kit from 
Bio-Rad Laboratories (Hercules, CA); enhanced chemilu-
minescence (ECL) system and Amersham hyperfilmTM 
ECL from GE Healthcare (Buckinghamshire, UK); sense 
and complement strands of human AMPK-α1 and α2 
siRNAs, siCONTROL complete kit, and 5 × siRNA buffer 
from Dharmacon Inc. (Lafayette, CO); 5'-ITC from Biomol 
Research Labs (Plymouth Meeting, PA).
Cell culture
Foreskin human fibroblasts were isolated from newborn 
foreskins as described previously (Boyce and Ham, 1983). 
Fibroblasts were maintained in 100-mm tissue culture 
dishes in DMEM supplemented with 10% FBS and 100 
U/ml penicillin and 100 μg/ml streptomycin, and maintained 
in 5% CO2 in a humidified incubator at 37oC. Cells from the 
early stage of culture (population doubling of less than 25) 
were utilized for this experiment. Prior to serum withdrawal, 
cells were grown for 2 days to 60-70% sub-confluence in 
the culture medium with 10% FBS in DMEM, and then 
serum-depleted by incubation with serum-free DMEM 
containing 0.1% bovine serum albumin (SFM) for 1-5 days. 
To examine the effect of serum and growth factors on 
GAPDH export from the nucleus, cells were cultured for 2 
days in 10% FBS in DMEM, then serum-starved for 4-5 
days, and then 10% FBS or agonists (PDGF or LPA) were 
added for the times indicated. For immunofluorescence 
staining, cells were cultured on coverslips in 6-well culture 
plates.
Western blot analysis
Protein expression levels were examined by Western blot 
analysis, as described previously (Yeo et al., 2000). Total 
cell lysates were prepared in a lysis buffer containing 50 
mM Tris-HCl (pH 7.5), 150 mM NaCl, 2 mM EDTA, 1 mM 
EGTA, 1 mM Na3VO4, 10 mM NaF, 1 mM DTT, 1 mM 
PMSF, 25 μg/ml leupeptin, 25 μg/ml aprotinin, 5 mM 
benzamidine, and 1% Ingepal CA630. Protein concen-
trations of the lysates were determined using a Bio-Rad 
protein assay kit, as described by the manufacturer. Cell 
lysates containing equal amounts of protein were resolved 
by SDS-PAGE and transferred onto Immobilon PVDF 
membranes. Blots were blocked with a solution containing 
5% nonfat dried milk or 5% BSA and 0.1% Tween 20, and 
treated with antibodies in the blocking solution overnight, 
then washed and further probed with HRP-conjugated 
anti-rabbit IgG (1:5,000). The immune complexes were 
visualized using an ECL detection system, as described by 
the manufacturer.
Transfection of siRNAs of human AMPK-α1 and α2
Target sequences for preparing siRNAs of human AMPK- 
α1 and α2 were as follows: 5'-AGUGAAGGUUGGCAAA-
CAUTT-3' (sense strand) and 5'-AUGUUUGCCAACCUU-
CACUTT-3' (complement strand) for human AMPK-α1; 5'- 
GGAAGGUAGUGAAUGCAUATT-3' (sense strand) and 5'- 
UAUGCAUUCACUACCUUCCTT-3' (complement strand) 
for human AMPK-α2. A siCONTROL complete kit was 
used as a negative mock control. Chemically synthesized 
RNA oligonucleotides were 2'-deprotected, annealed, and 
desalted as recommended by the manufacturer. RNA 
duplexes (100 μM stock) resuspended in 1 × siRNA buffer 
[6 mM HEPES-KOH (pH 7.5), 20 mM KCl, 0.2 mM MgCl2] 
were transfected with 2.0 × 104 HDF cells at 30-50% 
confluence. Transfection with siRNAs was performed using 
LipofectamineTM RNAiMAX in a 6-well plate as described 
by the manufacturer. For this purpose, 120 pmol of siRNA 
duplex was diluted in 100 μl of Opti-MEM I reduced serum 
medium, and 2 μl of LipofectamineTM RNAiMAX reagent in 
100 μl of Opti-MEM I reduced serum medium, and the 
diluted siRNA mix and lipid were combined, mixed gently, 
and incubated for 20 min at room temperature (RT). The 
lipid and siRNA mix was added to each well (total volume 
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1.2 ml, 100 nM siRNA). The medium was replaced with 
culture medium at 4 h after transfection and the cells were 
incubated for 24-72 h at 37oC. Cells were then analyzed for 
changes in AMPK protein expression by Western blotting.
Immunofluorescence staining
The cells on coverslips in 6-well culture plates were 
washed twice with ice-cold PBS and fixed in 4% 
paraformaldehyde in PBS for 10 min, and then washed 
once with PBS. Nonspecific protein- binding sites were 
saturated with blocking solution (2% BSA in TBST: 20 mM 
Tris, 138 mM NaCl, 0.1% Tween 20, pH 7.4) for 1 h with 
gentle shaking. The cells were incubated with primary 
monoclonal antibody against GAPDH (1:1,000 in blocking 
solution) for 1 h at RT and then washed three times with 
ice-cold TBST for 10 min each. Cells were incubated with 
FITC-conjugated goat anti-mouse secondary antibody 
(1:500) in blocking buffer for 1 h. Cells were washed three 
times with TBST for 10 min each and dehydrated in three 
washes of 100% methanol over 1 h. The coverslips were 
mounted on glass slides with solution including DAPI, 
which fluorescently (blue) labeled the nuclei. Fluorescence 
images were then observed by laser scanning confocal 
microscopy (FV500; Olympus, Tokyo, Japan).
    To compare the distribution of GAPDH, both FITC 
fluorescence (green indicates GAPDH location) and DAPI 
fluorescence (blue indicates the nuclear region) were 
examined. After cells were stained for cytosolic GAPDH, 
nuclear GAPDH, or both cytosolic and nuclear GAPDH, 
10-20 different fields of each sample were counted under 
the microscope at 100 × magnification. The data were 
combined to give total cell numbers of about 1,000 and 
were converted to percentage distribution. We repeated 
this experiment at least three times and statistically 
analyzed the data.
Statistical analysis
The Student's t-test for paired variables (Office Excel 2007; 
Microsoft, Redmond, WA) was used to determine whether 
the index was significantly different as a result of the 
treatment. Data are presented as the mean ± standard 
deviation of at least three experiments. P values of less 
than 0.05 were considered to be statistically significant.
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